Table. . Disease-specific reporting completeness proportions in North Carolina, USA, 2000–2006*.
| Communicable disease | No. reported to NC DHHS | No. identified by ICD-9-CM codes | Unadjusted RCP, % (95% CI) | Semi-Bayesian adjusted RCP, % (95% UI) |
|---|---|---|---|---|
| Anthrax | 0 | 14 | 0.01 (0.00–100.00) | 0.00 (0.00–100.00) |
| Arboviral encephalitis | 0 | 18 | 0.00 (0.00–100.00) | 8.67 (0.80–52.77) |
| Botulism | 0 | 4 | 0.02 (0.00–100.00) | 0.08 (0.00–100.00) |
| Brucellosis | 0 | 33 | 0.00 (0.00–100.00) | 23.02 (1.36–86.62) |
| Campylobacteriosis | 39 | 97 | 40.21 (30.94–50.22) | 39.96 (30.82–49.85) |
| Cholera | 0 | 6 | 0.01 (0.00–100.00) | 18.58 (2.24–69.41) |
| CJD/vCJD | 0 | 32 | 0.00 (0.00–100.00) | 0.87 (0.03–22.97) |
| Cryptosporidiosis | 10 | 84 | 11.90 (6.53–20.73) | 12.59 (7.07–21.42) |
| Cyclosporiasis | 0 | 3 | 0.03 (0.00–100.00) | 18.59 (2.25–69.42) |
| Dengue | 4 | 25 | 16.00 (6.14–35.69) | 14.48 (5.92–31.31) |
| Diphtheria | 0 | 5 | 0.02 (0.00–100.00) | 8.28 (0.82–49.70) |
| Escherichia coli infection | 1 | 3 | 33.33 (4.34–84.65) | 24.67 (5.82–63.45) |
| Foodborne staphylococcal infection | 0 | 14 | 0.01 (0.00–100.00) | 74.74 (16.74–97.76) |
| Granulocytic ehrlichiosis | 0 | 67 | 0.00 (0.00–100.00) | 8.66 (0.80–52.74) |
| Hantavirus infection | 0 | 3 | 0.03 (0.00–100.00) | 10.10 (0.62–67.06) |
| Hemolytic uremic syndrome | 5 | 429 | 1.17 (0.49–2.77) | 2.20 (0.99–4.84) |
| Hemophilus Influenzae | 14 | 1,086 | 1.29 (0.76–2.16) | 1.45 (0.87–2.42) |
| Hepatitis A | 27 | 866 | 3.12 (2.15–4.51) | 3.34 (2.31–4.81) |
| Legionellosis | 24 | 98 | 24.49 (16.99–33.95) | 24.04 (16.72–33.27) |
| Leptospirosis | 0 | 33 | 0.00 (0.00–100.00) | 23.02 (1.36–86.62) |
| Listeriosis | 10 | 64 | 15.63 (8.62–26.67) | 16.14 (9.12–26.95) |
| Lyme disease | 8 | 790 | 1.01 (0.51–2.01) | 1.18 (0.60–2.30) |
| Malaria | 17 | 155 | 10.97 (6.93–16.94) | 10.71 (6.80–16.47) |
| Measles | 0 | 14 | 0.01 (0.00–100.00) | 15.98 (1.41–71.63) |
| Meningococcal disease | 38 | 179 | 21.23 (15.85–27.83) | 21.19 (15.85–27.73) |
| Monocytic ehrlichiosis | 1 | 4 | 25.00 (3.35–76.22) | 14.84 (3.12–48.52) |
| Mumps | 1 | 96 | 1.04 (0.15–7.02) | 1.07 (0.20–5.49) |
| Plague | 0 | 28 | 0.00 (0.00–100.00) | 0.00 (0.00–100.00) |
| Pneumococcal meningitis | 20 | 191 | 10.47 (6.86–15.67) | 10.61 (6.99–15.80) |
| Polio, paralytic | 0 | 32 | 0.00 (0.00–100.00) | 18.56 (2.24–69.38) |
| Psittacosis | 0 | 21 | 0.00 (0.00–100.00) | 17.45 (1.57–73.69) |
| Q fever | 3 | 14 | 21.43 (7.07–49.43) | 25.68 (9.14–54.28) |
| Rabies, human | 0 | 12 | 0.01 (0.00–100.00) | 59.69 (8.00–96.19) |
| Rocky Mountain spotted fever | 40 | 986 | 4.06 (2.99–5.48) | 4.19 (3.10–5.66) |
| Rubella | 0 | 39 | 0.00 (0.00–100.00) | 15.97 (1.41–71.61) |
| Rubella congenital syndrome | 0 | 10 | 0.01 (0.00–100.00) | 1.08 (0.07–15.32) |
| Salmonellosis | 263 | 594 | 44.28 (40.33–48.30) | 44.82 (40.87–48.83) |
| SARS (coronavirus infection) | 0 | 1 | 0.08 (0.00–100.00) | 5.71 (0.28–56.27) |
| Shigellosis | 38 | 213 | 17.84 (13.26–23.57) | 18.17 (13.56–23.93) |
| Smallpox | 0 | 9 | 0.01 (0.00–100.00) | 0.00 (0.00–100.00) |
| Streptococcal infection, group A | 8 | 111 | 7.21 (3.65–13.75) | 7.40 (3.80–13.92) |
| Tetanus | 1 | 20 | 5.00 (0.70–28.22) | 5.25 (1.09–21.78) |
| Toxic shock syndrome | 4 | 142 | 2.82 (1.06–7.26) | 3.22 (1.28–7.83) |
| Trichinosis | 0 | 23 | 0.00 (0.00–100.00) | 20.21 (1.82–77.58) |
| Tuberculosis | 100 | 1,439 | 6.95 (5.74–8.38) | 7.10 (5.87–8.55) |
| Tularemia | 0 | 6 | 0.01 (0.00–100.00) | 0.04 (0.00–100.00) |
| Typhoid, acute | 3 | 12 | 25.00 (8.28–55.18) | 21.57 (7.49–48.30) |
| Typhus, epidemic (louse-borne) | 0 | 2 | 0.04 (0.00–100.00) | 2.93 (0.12–42.63) |
| Vaccinia | 0 | 13 | 0.01 (0.00–100.00) | 8.27 (0.82–49.68) |
| Vibrio spp. infection, other | 0 | 1 | 0.08 (0.00–100.00) | 81.58 (20.46–98.71) |
| Vibrio vulnificus infection | 0 | 2 | 0.04 (0.00–100.00) | 81.57 (20.45–98.71) |
| Whooping cough (pertussis) | 11 | 54 | 20.37 (11.65–33.16) | 20.31 (11.78–32.72) |
| Yellow fever | 0 | 3 | 0.03 (0.00–100.00) | 8.69 (0.80–52.81) |
*NC DHHS, North Carolina Department of Health and Human Services; ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification; RCP, reporting completeness proportions; CI, confidence interval; UI, uncertainty interval; CJD, Creutzfeldt-Jakob disease; vCJD, variant CJD; SARS, severe acute respiratory syndrome.